neuroFix Therapeutics Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

neuroFix Therapeutics General Information

Description

Developer of therapeutic products. The company develops NFC-1 a non-stimulant metabotropic glutamate receptor for the treatment of mGluR network mutation positive attention deficit hyperactivity disorder and neuropsychiatric symptoms in USA.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • DE
  • United States
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Aevi Genomic Medicine
Corporate Office
  • DE
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

neuroFix Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore neuroFix Therapeutics‘s full profile, request access.

Request a free trial

neuroFix Therapeutics Executive Team (1)

Name Title Board Seat
Hakon Hakonarson Ph.D Founder
To view neuroFix Therapeutics’s complete executive team members history, request access »

neuroFix Therapeutics FAQs

  • Who is the founder of neuroFix Therapeutics?

    Hakon Hakonarson Ph.D is the founder of neuroFix Therapeutics.

  • Where is neuroFix Therapeutics headquartered?

    neuroFix Therapeutics is headquartered in DE.

  • What industry is neuroFix Therapeutics in?

    neuroFix Therapeutics’s primary industry is Drug Discovery.

  • Is neuroFix Therapeutics a private or public company?

    neuroFix Therapeutics is a Private company.

  • What is the current valuation of neuroFix Therapeutics?

    The current valuation of neuroFix Therapeutics is 00000.

  • What is neuroFix Therapeutics’s current revenue?

    The current revenue for neuroFix Therapeutics is 000000.

  • When was neuroFix Therapeutics acquired?

    neuroFix Therapeutics was acquired on 09-Sep-2015.

  • Who acquired neuroFix Therapeutics?

    neuroFix Therapeutics was acquired by Aevi Genomic Medicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »